MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Utilizing Speech Analysis to Differentiate Progressive Supranuclear Palsy from Parkinson Disease

    K. Kang, A. Nunes, M. Sharma, A. Hall, R. Mishra, J. Casado, R. Cole, G. Barchard, A. Vaziri, A. Wills, A. Pantelyat (Baltimore, USA)

    Objective: To differentiate Progressive Supranuclear Palsy (PSP) from Parkinson Disease (PD) using speech analysis. Background: PD and PSP exhibit many clinical similarities including speech disorders…
  • 2023 International Congress

    Effect of levodopa on the interpretation of social interactions in people living with Parkinson’s disease

    T. Danaila, E. Metereau (Bron, France)

    Objective: Better understand the social interactions by assessing the effect of oral levodopa on the social cognition abilities in fluctuating PD patients without significant cognitive disorder.…
  • 2023 International Congress

    Changes in word fluency tasks and cognitive function before and after the COVID-19 epidemic in patients with Parkinson’s disease:PD.

    M. Sagawa, K. Hasegawa, A. Kumon, M. Saruwatari (Kanagawa, Japan)

    Objective: The purpose of this study is to investigate the changes in cognitive function and frontal lobe function in PD before and after self-restraint due…
  • 2023 International Congress

    Neurophysiological markers of motor reserve in Parkinson’s disease

    M. Passaretti, S. Rinaldo, E. Orunesu, D. Rossi Sebastiano, G. de Vigili, G. Barbiera, A. Braccia, G. Paparella, M. de Riggi, P. Lanteri, A. Berardelli, A P. Strafella, M. Bologna, R. Eleopra, R. Cilia (Rome, Italy)

    Objective: Our objective was to investigate Motor Reserve (MR) in idiopathic Parkinson’s Disease (PD). Background: MR is defined as the resilience mechanisms of the brain…
  • 2023 International Congress

    Impact of the severity of Parkinson’s disease on skin elasticity

    SY. You, HJ. Park (Daegu, Republic of Korea)

    Objective: To investigate changes in skin elasticity according to the severity of symptoms of Parkinson's disease. Background: Parkinson's disease (PD) is a neurodegenerative disease caused…
  • 2023 International Congress

    Touchscreen nQ application as a remote digital biomarker in Parkinson disease

    J. Yu, P. Gandara, O. Phillips, J. Liao, A. Holmes, I. Mondesire-Crump, J. Syrotenko, S. Mruthik, T. Arroyo-Gallego, H. Fernandez (Cleveland, USA)

    Objective: To characterize the viability of nQ machine learning platform via touchscreen keyboard as a digital biomarker for Parkinson disease Background: To date, a reliable…
  • 2023 International Congress

    Serum Metabolomics in Parkinson’s Disease: Correlations with Fecal Microbiome, Fecal Metabolomics and Clinical Status

    TS. Toh, CW. Chong, MF. Loke, JW. Hor, LC. Lit, J. Bowman, SL. Song, CSJ. Teh, S-Y. Lim, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To investigate the correlations between serum metabolites with fecal microbiome, fecal metabolites, and clinical phenotypes in patients with Parkinson’s disease (PD). Background: There is…
  • 2023 International Congress

    An international consensus statement for rehabilitation care in Parkinson’s disease

    J. Goldman, D. Volpe, T. Ellis, M. Hirsch, J. Johnson, J. Wood, A. Aragon, R. Biundo, A. Dirocco, G. Kasman, R. Iansek, J. Miyasaki, V. Mcconvey, M. Munneke, S. Pinto, K. St Clair, S. Toledo, M. York, R. Todaro, N. Yarab, K. Wallock (Chicago, USA)

    Objective: To develop a consensus statement regarding the incorporation of rehabilitation in Parkinson’s (PD) care. Background: As a complex, progressive disorder, PD can impact daily…
  • 2023 International Congress

    Neuropsychiatric Symptoms in Early-Onset Parkinson’s Disease

    C. Piat, E. Camerucci, A. Mullan, K. Ghoniem, J. Jacobson, G. Patanè, P. Turcano, R. Savica (Rochester, USA)

    Objective: To describe the neuropsychiatric symptoms of Early-Onset Parkinson’s Disease (EOPD) patients in an incident cohort study from 1991 to 2010 in Olmsted County, Minnesota…
  • 2023 International Congress

    Effects on voice sound level and brain connectivity after HiCommunication: a novel speech and communication treatment for Parkinson’s disease

    H. Steurer, F. Albrecht, A. Razi, J. Körner Gustafsson, E. Franzén, E. Schalling (Stockholm, Sweden)

    Objective: This study aimed to evaluate the clinical relevance of effects on voice sound level (Lv) as well as brain connectivity using resting-state functional MRI…
  • « Previous Page
  • 1
  • …
  • 401
  • 402
  • 403
  • 404
  • 405
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley